Patents by Inventor Jonathan Q. Tran

Jonathan Q. Tran has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for improving pharmacokinetics
    Patent number: 10918626
    Abstract: The object of the present invention is to inhibit oxidative metabolism of a compound of formula I by co-administration with ritonavir, a cytochrome P450 inhibitor.
    Type: Grant
    Filed: April 8, 2020
    Date of Patent: February 16, 2021
    Assignee: Roche Palo Alto LLC
    Inventor: Jonathan Q. Tran
  • METHOD FOR IMPROVING PHARMACOKINETICS
    Publication number: 20200230112
    Abstract: The object of the present invention is to inhibit oxidative metabolism of a compound of formula I by co-administration with ritonavir, a cytochrome P450 inhibitor.
    Type: Application
    Filed: April 8, 2020
    Publication date: July 23, 2020
    Applicant: Roche Palo Alto LLC
    Inventor: Jonathan Q. TRAN
  • METHOD FOR IMPROVING PHARMACOKINETICS
    Publication number: 20180318267
    Abstract: The object of the present invention is to inhibit oxidative metabolism of a compound of formula I by co-administration with ritonavir, a cytochrome P450 inhibitor.
    Type: Application
    Filed: July 11, 2018
    Publication date: November 8, 2018
    Applicant: Roche Palo Alto LLC
    Inventor: Jonathan Q. TRAN
  • METHOD FOR IMPROVING PHARMACOKINETICS
    Publication number: 20170119739
    Abstract: The object of the present invention is to inhibit oxidative metabolism of a compound of formula I by co-administration with ritonavir, a cytochrome P450 inhibitor.
    Type: Application
    Filed: January 12, 2017
    Publication date: May 4, 2017
    Applicant: Roche Palo Alto LLC
    Inventor: Jonathan Q. Tran
  • METHOD FOR IMPROVING PHARMACOKINETICS
    Publication number: 20100272682
    Abstract: The object of the present invention is to elevate the blood levels of a compound of formula I by co-administration with a cytochrome P450 inhibitor.
    Type: Application
    Filed: April 23, 2010
    Publication date: October 28, 2010
    Inventor: Jonathan Q. Tran